A new trading day began on Friday, with Atyr Pharma Inc (NASDAQ: ATYR) stock price up 9.00% from the previous day of trading, before settling in for the closing price of $3.00. ATYR’s price has ranged from $1.42 to $4.66 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 429.49% over the past five years. Meanwhile, its annual earnings per share averaged 23.15%. With a float of $86.06 million, this company’s outstanding shares have now reached $89.00 million.
Let’s look at the performance matrix of the company that is accounted for 59 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Atyr Pharma Inc (ATYR) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Atyr Pharma Inc is 3.22%, while institutional ownership is 70.08%. The most recent insider transaction that took place on Mar 17 ’25, was worth 15,000. In this transaction Director of this company bought 3,750 shares at a rate of $4.00, taking the stock ownership to the 9,750 shares. Before that another transaction happened on Feb 04 ’25, when Company’s Chief Financial Officer sold 1,254 for $3.78, making the entire transaction worth $4,740. This insider now owns 31,763 shares in total.
Atyr Pharma Inc (ATYR) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 23.15% per share during the next fiscal year.
Atyr Pharma Inc (NASDAQ: ATYR) Trading Performance Indicators
Here are Atyr Pharma Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.79.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.81, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.57 in one year’s time.
Technical Analysis of Atyr Pharma Inc (ATYR)
Atyr Pharma Inc (NASDAQ: ATYR) saw its 5-day average volume 1.53 million, a positive change from its year-to-date volume of 1.31 million. As of the previous 9 days, the stock’s Stochastic %D was 18.63%. Additionally, its Average True Range was 0.27.
During the past 100 days, Atyr Pharma Inc’s (ATYR) raw stochastic average was set at 41.10%, which indicates a significant decrease from 42.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 84.11% in the past 14 days, which was lower than the 87.13% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.28, while its 200-day Moving Average is $2.98. Nevertheless, the first resistance level for the watch stands at $3.42 in the near term. At $3.56, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.75. If the price goes on to break the first support level at $3.09, it is likely to go to the next support level at $2.90. The third support level lies at $2.76 if the price breaches the second support level.
Atyr Pharma Inc (NASDAQ: ATYR) Key Stats
With a market capitalization of 291.04 million, the company has a total of 89,004K Shares Outstanding. Currently, annual sales are 240 K while annual income is -64,020 K. The company’s previous quarter sales were 0 K while its latest quarter income was -14,880 K.
